Prone to feel guilty: Self-evaluative emotions in alcohol-dependence

Grynberg, Delphine; Timary, Philippe de; Heuverswijn, Aude Van; Maurage, Pierre

doi:10.1016/j.drugalcdep.2017.06.030

Cited by 17 publications

(24 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There may be several reasons why PWID with AUD are less likely to receive HCV care in France than PWID without AUD, including stigmatization , affective disorders , a sense of guilt , depression and impaired social cognition . The increased HCV treatment uptake which we observed for AUD‐treated patients was to be expected, given that AUD treatment is supposed to counteract these factors.…”

Section: Discussionmentioning

confidence: 72%

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

et al. 2019

View full text Add to dashboard Cite

Background and Aims Although people who inject drugs (PWID) are the core at‐risk population in the hepatitis C virus (HCV) epidemic in industrialized countries, few initiate treatment. Alcohol use disorder (AUD), common within this population, has been identified as a barrier to HCV treatment uptake in the general population. We investigated whether the arrival of new and well‐tolerated HCV treatments (direct‐acting antivirals: DAA) has improved HCV treatment uptake in French PWID compared with former treatments (pegylated interferon‐based treatments: Peg‐IFN). Design Using discrete‐time Cox proportional hazards models based on exhaustive care delivery data, we tested for associations between AUD (defined by AUD‐related long‐term illness status, diagnosis coding during hospitalization and/or AUD pharmacological treatment) and first HCV treatment delivery, after adjusting for gender, age, complementary universal health cover, liver disease severity and type of opioid agonist therapy (OAT) received. Separate analyses were performed for 2012–13 (Peg‐IFN era) and 2014–16 (DAA era). Setting France. Participants All French people chronically HCV‐infected who received OAT at least once during 2012–16 and were covered by the national health insurance (n = 24 831). Measurements Incidence rate of HCV treatment uptake, hazard ratios associated with AUD and other covariates. Findings Incidence rate (IR) of HCV treatment uptake per 100 person‐years was 6.56, confidence interval (CI) = 6.30–6.84; and IR = 5.70, 95% CI = 5.51–5.89 for Peg‐IFN‐based treatment (2012–13) and DAA (2014–16), respectively. After multiple adjustment, people with AUD not receiving related medication had 30 and 14% lower Peg‐IFN‐based treatment and DAA uptake, respectively, than those without AUD [hazard ratio (HR) = 0.70, 95% CI = 0.62–0.80 and HR = 0.86, 95% CI = 0.78–0.94]. No difference was observed between those treated for AUD and those without AUD. Conclusions Despite the benefits of direct‐acting antiviral treatment, untreated alcohol use disorder appears to remain a major barrier to hepatitis C virus treatment access for people who inject drugs in France.

show abstract

Section: Discussionmentioning

confidence: 72%

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

et al. 2019

View full text Add to dashboard Cite

show abstract

“…However, the multivariate analysis revealed that it was feelings of guilt, rather than shame, that had a significant relationship with the presence of alcohol dependence. Previous research that had indicated a relationship between alcohol use and problems of shame and guilt was conducted extensively with college samples (Dearing et al, 2005;Treeby & Bruno, 2012;Ianni et al, 2010;Rodriguez et al, 2015;Stuwig & Tangney, 2007), with the exception of several studies which were carried out ------IJADR 9(1) ------in clinical samples (Grynberg et al, 2017;Meehan et al, 1996;O'Connor et al, 1994). Meehan and colleagues (1996) compared individuals recovering from drug abuse with nonaddicted individuals and found that the drug addicted individuals had a higher level of Shame.…”

Section: Discussionmentioning

confidence: 99%

“…Depression (Boden & Fergusson, 2011), and anxiety (Bellos et al, 2013;Çelik, et al, 2002;Chen et al, 2015) are the most common comorbid disorders in alcohol dependence, and usually require assessment of related negative emotions and psychosocial intervention. Shame and guilt are two negative emotions commonly associated with alcohol use problems (Patock-Peckham et al, 2018;Grynberg et al, 2017). However, it may be difficult for both the counsellor and the patient to discriminate between these two feelings during the treatment process.…”

Section: Introductionmentioning

confidence: 99%

Forgiveness, guilt, and shame in alcohol dependence: A comparative study in a Turkish sample

Vatansever

İlhan

2021

IJADR

View full text Add to dashboard Cite

Aims: The purpose of the present study was to compare individuals with and without alcohol dependence in terms of forgiveness, shame, and guilt. A further purpose was to investigate the association of shame and guilt with alcohol dependence. Methods: Fifty-five individuals with and 55 without alcohol dependence (based on ICD-10 criteria) were compared using the Heartland Forgiveness Scale (HFS), and Trait Shame and Guilt Scale (TSGS). Results: Individuals with alcohol dependence showed a significantly lower level of self-forgiveness, pride and a significantly higher level of both shame and guilt than the non-alcohol dependent group in the univariate analysis. However, only guilt was related to the presence of alcohol dependence in the multivariate analysis. Self-forgiveness was negatively correlated with both shame and guilt in the alcohol-dependent individuals, but not among individuals without alcohol use problems. Conclusions: The findings of this study support the importance of the self-conscious emotions of shame and guilt in alcohol dependence, together with self-forgiveness. These psychological states should be considered in the treatment of alcohol dependence.

show abstract

“…While we did not find evidence that any particular motivation or reason for keeping the secret was associated with fear of discovery, we did observe that secrets concerning addiction were associated with greater fear of discovery across the two studies. People with an addiction (whether to alcohol, psychoactive substances like nicotine or morphine, or gambling) not only tend to be ashamed or embarrassed by their addiction (e.g., Grynberg et al, 2017), they have an inability to control the addicted behavior, and consequently increase their risk of exposure. However, people with a secret addiction are not the only people who might fear discovery.…”

Section: Discussionmentioning

confidence: 99%

Secrets, Psychological Health, and the Fear of Discovery

Davis

Brazeau

Xie

et al. 2020

Pers Soc Psychol Bull

View full text Add to dashboard Cite

Keeping secrets from one’s partner has been associated with lower well-being and relationship satisfaction. Previous research has suggested that individual differences in self-concealment account for these effects. However, we propose that the fear of discovery (FoD)—defined as the fear that one’s secret may be revealed by means other than deliberate disclosure—predicts the extent to which secrets affect well-being beyond the effects attributable to individual differences. Both a cross-sectional and a longitudinal survey (combined N = 471; 54.4% female; Mage = 39.5) of adults in romantic relationships confirmed that FoD predicted greater preoccupation with the secret, more negative affect, and less relationship satisfaction and commitment beyond that of self-concealment. Multilevel modeling in Study 2 indicated that changes in FoD predicted changes in preoccupation over time. The data are consistent with the notion that FoD promotes greater preoccupation, greater negative affect, and lower levels of relationship well-being.

show abstract

Prone to feel guilty: Self-evaluative emotions in alcohol-dependence

Cited by 17 publications

References 38 publications

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

Forgiveness, guilt, and shame in alcohol dependence: A comparative study in a Turkish sample

Secrets, Psychological Health, and the Fear of Discovery

Contact Info

Product

Resources

About